Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33797393&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil #MMPMID33797393
Fintelman-Rodrigues N; da Silva APD; Dos Santos MC; Saraiva FB; Ferreira MA; Gesto J; Rodrigues DAS; Vale AM; de Azevedo IG; Soares VC; Jiang H; Tan H; Tschoeke DA; Sacramento CQ; Bozza FA; Morel CM; Bozza PT; Souza TML
Emerg Infect Dis 2021[May]; 27 (5): 1446-1453 PMID33797393show ga
The dynamics underlying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection remain poorly understood. We identified a small cluster of patients in Brazil who experienced 2 episodes of coronavirus disease (COVID-19) in March and late May 2020. In the first episode, patients manifested an enhanced innate response compared with healthy persons, but neutralizing humoral immunity was not fully achieved. The second episode was associated with different SARS-CoV-2 strains, higher viral loads, and clinical symptoms. Our finding that persons with mild COVID-19 may have controlled SARS-CoV-2 replication without developing detectable humoral immunity suggests that reinfection is more frequent than supposed, but this hypothesis is not well documented.